Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Mantle-Cell 7Lymphoma, Follicular 5Lymphoma, B-Cell 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, B-Cell, Marginal Zone 2Hematologic Neoplasms 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Plasmablastic Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Primary Effusion 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Hodgkin Disease 1Hematopoietic and Lymphoid System Neoplasm 1HIV Infections 1Composite Lymphoma 1Blast Crisis 1

Interventions

Cyclophosphamide 5Brentuximab Vedotin 5Vincristine 4Rituximab 4Peripheral Blood Stem Cell Transplantation 4Ifosfamide 4Etoposide 4Doxorubicin 4Carboplatin 4romidepsin 3fludarabine phosphate 3brigatinib 3Prednisone 3Lenalidomide 3Everolimus 310-propargyl-10-deazaaminopterin 3pembrolizumab 2indolepropanol phosphate 2Whole-Body Irradiation 2Vorinostat 2Mycophenolic Acid 2Microarray Analysis 2Immunohistochemistry 2Gene Expression Profiling 2Cytarabine 2Cyclosporine 2Clofarabine 2Bendamustine Hydrochloride 2veliparib 1repotrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Lymphoma, Large-Cell, Anaplastic × CT-P10 × Clear all
NCT01035463 2023-10-10

Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma

University of Nebraska

Phase 1/2 Completed
74 enrolled 11 charts
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡